deficiencies in a male with cardiomyopathy and 3-methylglutaconic aciduria, ” J Inherit Metab Dis

Abnormal Mitochondria

Arbelaez A

Castillo M

X-linked Carioskelatal Myopathy

CiteSeerX

 3-METHYLGLUTACONIC ACIDURIA TYPE II (MGA TYPE II) REFERENCES 
(X-LINKED CARIOSKELATAL MYOPATHY, NEUTROPENIA & ABNORMAL MITOCHONDRIA, BARTH 
SYNDROME; MGA, TYPE II) 
 
1.  Al-Essa M, Bakheet S, Al-Shamsan L, Patay Z, Powe J, Ozand PT. “18fluoro-2-deoxyglucose 
(18FDG) PET scan of the brain in type IV 3-methylglutaconic aciduria: clinical and MRI correlation,” 
Brain De v 1999; 21(1): 24-29.  
2.  al Aqeel A, Rashed M, Ozand PT, Brismar J, Gascon GG, al Odaib A, Dabbagh O. “3-
methylglutaconic aciduria: ten new cases with a possible new phenotype,” Brain Dev. 1994 Nov; 16 
Suppl: 23-32.  
3.  Anikster Y, Kleta R, Shaag A, Gahl WA, Elpeleg O. “Type III 3-methylglutaconic aciduria (optic 
atrophy plus syndrome, or costeff optic atrophy syndrome): identification of the OPA3 gene and its 
found mutation in Iraqi Jews,” Am J Hum Genet 2001; 69(6): 1218-1224  
4.  Arbelaez A, Castillo M, Stone J. “MRI in 3-methylglutaconic aciduria type 1,” Neuroradiology 1999; 
41(12): 941-942.  
5.  Bakkeren JA, Sengers RC, Ruitenbeek W, Trijbels JM. “3-methylglutaconic aciduria in a patient with 
a disturbed mitochondrial energy metabolism,” Eur J Pediatr. 1992 Apr; 151(4): 313.  
6.  Barth PG, Valianpour F, Bowen VM, Lam J, Duran M, Vaz FM, Wanders RJ. “X-linked cardio 
skeletal myopathy and neutropenia (barth syndrome): an update,” Am J Med Genet. 2004 May 1, 
126A(4): 349-54.  
7.  Barth PG, Wanders RJ, Vreken P. “X-linked cardio skeletal myopathy and neutropenia (barth 
syndrome) MIM 302060,” J Pediatr 1999; 135(3): 273-276.  
8.  Barth PG, Wanders RJ, Vreken P, Janssen EA, Lam J, Baas F. “X-linked cardio skeletal myopathy and 
neutropenia (barth syndrome) (MIM 302060),” J Inherit Metab Dis 1999; 22(4): 555-567.  
9.  Besley GT, Lendon M, Broadhead DM, Till J, Heptinstall LE, Phillips B. “Mitochondrial complex 
deficiencies in a male with cardiomyopathy and 3-methylglutaconic aciduria,” J Inherit Metab Dis. 
1995; 18(2): 221-3.  
10.  Brandt NJ. “Symptoms and Signs in Organic Acidurias,” J Inher Metab Dis 1984, 7(suppl 1): 23-27.  
11.  Broide E, Elpeleg O, Lahat E. “Type IV 3-methylglutaconic (3MGC) aciduria: a new case presenting 
with hepatic dysfunction,” Pediatr Neurol 1997; 17(4): 353-355.  
12.  Burlina A, Manara R, Calderone M, Catuogno S, Burlina AP. “Early diagnosis of metabolic stroke in 
branched-chain organic acidurias without metabolic decompensation,” J Inherit Metab Dis 2002; 
25(suppl.1): 45.  
13.  Cantlay AM, Shokrollahi K, Allen JT, Lunt PW, Newbury-Ecob RA, Steward CG. “Genetic analysis 
of the G4.5 gene in families with suspected barth syndrome,” J Pediatr 1999; 135(3): 311-315.  
14.  Cardonick EH, Kuhlman K, Ganz E, Pagotto LT. “Prenatal clinical expression of 3-methylglutaconic 
aciduria: barth syndrome,” Prenat Diagn 1997; 17(10): 983-988.  
15.  Chace DH, DiPerna JC, Mitchell BL, Sgroi B, Hofman LF, Naylor EW. “Electrospray Tandem Mass 
Spectrometry for Analysis of Acylcarnitines in Dried Postmortem Blood Specimens Collected at 
Autopsy from Infants with Unexplained Cause of Death,” Clin Chem 2001; 47(7): 1166-1182.  
16.  Chitayat D, Chemke J, Gibson KM, Mamer OA, Kronick JB, McGill JJ, Rosenblatt B, Sweetman L, 
Scriver CR. “3-methylglutaconic aciduria: a marker for as yet unspecified disorders and the relevance 
of prenatal diagnosis in a 'new' type ('type 4'),” J Inherit Metab Dis. 1992; 15(2): 204-12.  
17.  Costeff H, Apter N, Elpeleg ON, Prialnic M, Bohles HJ. “Ineffectiveness of oral coenzyme Q10 
supplementation in 3-methylglutaconic aciduria, type 3,” Brain Dev 1998; 20(1): 33-35.  
18.  Costeff H, Elpeleg ON. “3-methylglutaconic aciduria, type 3,” Brain Dev 1995; 17(3): 226.  
19.  Costeff H, Elpeleg O, Apter N, Divry P, Gadoth N. “3-methylglutaconic aciduria in ‘optic atrophy 
plus,” Ann Neurol. 1993 Jan; 33(1): 103-4.  
20.  Christodoulou J, McInnes RR, Jay V, Wilson G, Becker LE, Lehotay DC, Platt BA, Bridge PJ, 
Robinson BH, Clarke JT. “Barth syndrome: clinical observations and genetic linkage studies,” Am J 
Med Genet. 1994 Apr 15; 50(3): 255-64.  
21.  DeKoning T, Duran M, Dorland L, Berger R, Poll-The BT. “Maternal 3-methylglutaconic aciduria 
associated with abnormalities in offspring,”, Lancet 1996; 348(9031: 887-888.  
22.  Draaisma JM, van Kesteren IC, Daniels O, Sengers RC. “Dilated cardiomyopathy with 3-
methylglutaconic aciduria,” Pediatr Cardiol. 1994 Mar-Apr; 15(2): 89-90.  23.  Duran M, Beemer FA, Tibosch AS, Bruinvis L, Ketting D, Wadman SK. “Inherited 3-
methylglutaconic aciduria in two brothers--another defect of leucine metabolism,” J Pediatr. 1982 Oct; 
101(4): 551-4.  
24.  Elpeleg ON, Costeff H, Joseph A, Shental Y, Weitz R, Gibson KM. “3-methylglutaconic aciduria in 
the Iraqi-Jewish 'optic atrophy plus' (costeff) syndrome,” Dev Med Child Neurol. 1994 Feb; 36(2): 
167-2. 
25.  Ensenauer R, Muller CB, Schwab KO, Gibson KM, Brandis M, Lehnert W. “3-methylglutaconyl-CoA 
hydratase deficiency: a new patient with speech retardation as the leading sign,” J Inherit Metab Dis 
2000; 23(4): 341-344.  
26.  Gibson KM, Bennett MJ, Mize CE, Jakobs C, Rotig A, Munnich A, Lichter-Konecki U, Trefz FK. “3-
methylglutaconic aciduria associated with pearson syndrome and respiratory chain defects,” J Pediatr. 
1992 Dec; 121(6): 940-2.  
27.  Gibson KM, Lee CF, Wappner RS. “3-methylglutaconyl-coenzyme-A hydratase deficiency: a new 
case,” J Inherit Metab Dis. 1992; 15(3): 363-6.  
28.  Gibson KM, Wappner RS, Jooste S, Erasmus E, Mienie LJ, Gerlo E, Desprechins B, De Meirleir L. 
“Variable clinical presentation in three patients with 3-methylglutaconyl-coenzyme A hydratase 
deficiency,” J Inherit Metab Dis 1998; 21(6): 631-638.  
29.  Holme E, Greter J, Jacobson CE, Larsson NG, Lindstedt S, Nilsson KO, Oldfors A, Tulinius M. 
“Mitochondrial ATP-synthase deficiency in a child with 3-methylglutaconic aciduria,” Pediatr Res. 
1992 Dec; 32(6): 731-5.  
30.  Holtmann MG, Galle PR, Stremmel W, Mayatepek E. “3-methylglutaconic aciduria associated with 
hepatosplenomegaly, macrocytic anaemia, fever episodes, recurrent infections, cervical 
lymphadenopathy and progressive decrease of physical performance,” J Inherit Metab Dis 1998; 1(6): 
683-685.  
31.  Hou JW, Wang TR. “3-methylglutaconic aciduria presenting as reye syndrome in a chinese boy,” J 
Inherit Metab Dis. 1995; 18(5): 645-6. 
32.   Ibel H, Endres W, Hadorn HB, Deufel T, Paetzke I, Duran M, Kennaway NG, Gibson KM. “Multiple 
respiratory chain abnormalities associated with hypertrophic cardiomyopathy and 3-methylglutaconic 
aciduria,” Eur J Pediatr. 1993 Aug; 152(8): 665-70.  
33.  Ijlst L, Loupatty FJ, Ruiter JP, Duran M, Lehnert W, Wanders RJ. “3-methylglutaconic aciduria type I 
is caused by mutations in AUH,” Am J Hum Genet 2002, 71(6): 1463-1466.   
34.  Johnston J, Kelley RI, Feigenbaum A, Cox GF, Iyer GS, Funanage VL, Proujansky R. “Mutation 
characterization and genotype-phenotype correlation in barth syndrome,” Am J Hum Genet 1997; 
61(5): 1053-1058.  
35.  Jooste S, Erasmus E, Mienie LJ, de Wet WJ, Gibson KM. “The detection of 3-methylglutarylcarnitine 
and a new dicarboxylic conjugate, 3-methylglutaconylcarnitine, in 3-methylglutaconic aciduria,” Clin 
Chim Acta. 1994 Oct 14; 230(1): 1-8.  
36.  Kahler SG, Sherwood WG, Woolf D, Lawless ST, Zaritsky A, Bonham J, Taylor CF, Clarke JTR,  
Durie P, Leonard JV. “Pancreatitis in patients with organic acidemias,” J Pediatr 1994; 124(2): 239-
243.  
37.  Kelley RI, Cheatham JP, Clark BJ, Nigro MA, Powell BR, Sherwood GW, Sladky JT, Swisher WP. 
“X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic 
aciduria,” J Pediatr. 1991 Nov; 119(5): 738-47.  
38.  Kelley RI, Kratz L. “3-methylglutaconic acidemia in Smith-Lemli-Opitz syndrome,” Pediatr Res. 1995 
May, 37(5): 671-4.  
39.  Kleta R, Skovby F, Christensen E, Rosenberg T, Gahl WA, Anikster Y. “3-methylglutaconic aciduria 
type III in a non-Iraqi-Jewish kindred: clinical and molecular findings,” Mol Genet Metab 2002; 76(3): 
201-206.  
40.  Kuhara T, Matsumoto I, Saiki K, Takabayashi H, Kuwabara S. “3-methylglutaconic aciduria in two 
adults,” Clin Chim Acta. 1992 Apr 30; 207(1-2): 151-3.  
41.  Laube GF, Leonard JV, van't Hoff WG. “Nephrocalcinosis and medullary cysts in 3-methylglutaconic 
aciduria,” Pediatr Nephrol. 2003 Jul; 18(7): 712-3. Epub 2003 May 15.  
42.  Lichter-Konecki U, Trefz FK, Rotig A, Munnich A, Pfeil A, Bremer HJ. “3-methylglutaconic aciduria 
in a patient with pearson syndrome,” Eur J Pediatr. 1993 Apr; 152(4): 378.  43.  Ly TB, Peters V, Gibson KM, Liesert M, Buckel W, Wilcken B, Carpenter K, Ensenauer R, Hoffmann 
GF, Mack M, Zschocke J. “Mutations in the AUH gene cause 3-methylglutaconic aciduria,” Hum 
Mutat 2003; 21(4): 401-407.  
44.  Mazzocco MM, Kelley RI. “Preliminary evidence for a cognitive phenotype in barth syndrome,” Am J 
Med Genet 2001; 102(4): 372-378.  
45.  Michelson M, Harel S, Gutman A, Lerman-Sagie T. “Urinary organic acid screening in children with 
developmental language delay,” J Inherit Metab Dis 1999; 22(7): 815-820.  
46.  Millington DS. “Interpretation and follow-up of abnormal newborn screening results from MS/MS,” 
2004 Newborn Screening & Genetics Testing Symposium, May 3, 2004, Atlanta, GA  
47.  Morris AA, Leonard JV. “Early recognition of metabolic decompensation,” Arch Dis Child. 1997 Jun; 
76(6): 555-6.  
48.  Nysteun A, Costeff H, Elpeleg ON, Apter N, Bonne-Tamir B, Mohrenweiser H, Haider N, Stone EM, 
Sherrield VC. “Iraqi-Jewish kindreds with optic atrophy plus (3-methylglutaconic aciduria type 3) 
demonstrate linkage disequilibrium with the CTG repeat in the 3’ untranslated region of the myotonic 
dystrophy protein kinase gene,” Hum Mol Genet 1997; 6(4): 563-9.  
49.  Ogier H, Saudubray JM. “Branched-chain organic acidurias,” Semin Neonatol 2002; 7: 65-74.  
50.  OMIM- Online Mendelian Inheritance in Man; 3-@METHYLGLUTACONICACIDURIA, TYPE I-
#250950. 
51.  OMIM- Online Mendelian Inheritance in Man; 3-@METHYLGLUTACONICACIDURIA, TYPE II-
BARTH SYNDROME; BTHS- #302060. 
52.  OMIM- Online Mendelian Inheritance in Man; 3-@METHYLGLUTACONICACIDURIA, TYPE III-
#258501. 
53.  OMIM- Online Mendelian Inheritance in Man; 3-@METHYLGLUTACONICACIDURIA, TYPE IV-
250951. 
54.  Ostman-Smith I, Brown G, Johnson A, Land JM. “Dilated cardiomyopathy due to type II X-linked 3-
methylglutaconic aciduria: successful treatment with pantothenic acid,” Br Heart J. 1994 ct, 72(4): 
349-53. 
55.  Pantaleoni C, D’Arrigo S, D’Incerti L, Rimoldi M, Riva D. “A case of 3-methylglutaconic aciduria 
misdiagnosed as cerebral palsy,” Pediatr Neurol 2000; 23(5): 442-444. 
56.  Rahbek Schmidt M, Birkebaek N, Gonzalez I, Sunde L. “Barth syndrome without 3-methylglutaconic 
aciduria,” Acta Paediatr 2004; 93: 419-429.  
57.  Rousson R, Guibaud P. “Long Term Outcome of Organic Acidurias: Survey of 105 French Cases  
(1967-1983),” J Inher Metab Dis 1984, 7(suppl 1): 10-12.  
58.  Sakamoto O, Kitoh T, Ohura T, Ohya N, Iinuma K. “Novel missense mutation (R94S) in the TAZ 
(G4.5) gene in a Japanese patient with barth syndrome,” J Hum Genet 2002; 47(5): 229-231. 
59.  Seashore M. “The Organic Acidemias: An Overview,” www.geneclinics.org  
60.  Sheffer RN, Zlotogora J, Elpeleg ON, Raz J, Ben-Ezra D. “Behr's syndrome and 3-methylglutaconic 
aciduria,” Am J Ophthalmol. 1992 Oct 15; 114(4): 494-7.  
61.  Shoji Y, Takahashi T, Sawaishi Y, Ishida A, Matsumori M, Shoji Y, Enoki m, Watanabe H, Takada G. 
“3-methylglutaconic aciduria type I: clinical heterogeneity as a neurometabolic disease,” J Inherit 
Metab Dis 1999; 22(1): 1-8.  
62.  Sweetman L. “Prenatal Diagnosis of the Organic Acidurias,” J Inher Metab Dis 1984, 7(suppl 1): 18-
22.  
63.  Sweetman L, Williams JC. Branched Chain Organic Acidurias In: C. Scriver, A.L. Beaudet, W. Sly 
and D. Valle, Editors, The Metabolic and Molecular Basis of Inherited Disease (eighth ed.), McGraw-
Hill, New York (2001), pp. 2125–2163.  
64.  Walsh R, Conway H, Roche G, Naughten E, Mayne PD. “What is the origin of 3-methylglutaconic 
acid?” J Inher Metab Dis 1999; 22: 251-155.  
65.  Walsh R, Conway H, Roche G, Naughten E, Mayne PD. “3-methylglutaconic aciduria in pregnancy,” 
Lancet 1997; 349(9054): 776.  
66.   Zeharia A, Elpeleg ON, Mukamel M, Weitz R, Ariel R, Mimouni M. “3-methylglutaconic aciduria: a 
new variant,” Pediatrics. 1992 Jun 89(6 Pt 1): 1080-2. 
 

atrophy plus syndrome, or costeff optic atrophy syndrome): identification of the OPA3 gene and its

http://www.idph.state.ia.us/genetics/common/pdf/mga_type2_ref.pdf

atrophy plus syndrome, or costeff optic atrophy syndrome): identification of the OPA3 gene and its

Abstract

Similar works

Full text

Available Versions

CiteSeerX